Literature DB >> 9270572

High prevalence of Parkinson's disease in the Faroe Islands.

L Wermuth1, P Joensen, N Bünger, B Jeune.   

Abstract

We used several case-findings methods and strict criteria for case ascertainment to diagnose parkinsonism and idiopathic Parkinson's disease (PD) in the Faroe Islands. In the last few years before the prevalence date of July 1, 1995, we searched various registries from pharmacies, hospitals, and general practices, and found 195 patients with suspected parkinsonism out of 43,709 inhabitants. After excluding those who died before the prevalence date or were treated with levodopa (LD) for other diseases, a total of 124 patients remained for study, of whom 122 participated. We found 102 patients with parkinsonism and 82 with PD versus the expected 53 (p < 0.001, age-specific prevalences in the county of Rogaland, Norway). The overall prevalence of PD was estimated to be 187.6 and the age-adjusted prevalence to be 183.3 versus 110.9 per 100,000 inhabitants in the county of Rogaland. Compared to the study from Rogaland, the mean age at onset of PD symptoms, the mean age at the prevalence date, and the duration of PD indicated that the higher prevalence was not due to either an early onset nor to a longer duration of PD. A lower proportion of definite PD, a lower mean score on the Hoehn-Yahr scale, and a lower average dose of LD suggest that the high prevalence may be due to early diagnosis and a higher ascertainment of cases with mild disease. However, a high incidence cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9270572     DOI: 10.1212/wnl.49.2.426

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  16 in total

1.  Hyperintensity of the middle cerebellar peduncles on fluid-attenuated inversion recovery imaging: variation with age and implications for the diagnosis of multiple system atrophy.

Authors:  S Ngai; Y M Tang; L Du; S Stuckey
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

Review 2.  Epidemiological evidence on multiple system atrophy.

Authors:  N Vanacore
Journal:  J Neural Transm (Vienna)       Date:  2005-12       Impact factor: 3.575

3.  Prevalence of neurodegenerative parkinsonism in an isolated population in south-eastern Moravia, Czech Republic.

Authors:  Katerina Mensikova; Petr Kanovsky; Michaela Kaiserova; Lenka Mikulicova; Miroslav Vastik; Petr Hlustik; Petr Jugas; Josef Ovecka; Vladimír Janout
Journal:  Eur J Epidemiol       Date:  2013-07-26       Impact factor: 8.082

Review 4.  A systematic review of the incidence and prevalence of long-term neurological conditions in the UK.

Authors:  Thomas Hoppitt; Hardev Pall; Mel Calvert; Paramjit Gill; Guiqing Yao; Jill Ramsay; Gill James; Jacky Conduit; Cath Sackley
Journal:  Neuroepidemiology       Date:  2010-11-17       Impact factor: 3.282

5.  Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population.

Authors:  Jónrit Halling; Maria S Petersen; Per Damkier; Flemming Nielsen; Philippe Grandjean; Pál Weihe; Stefan Lundgren; Mia Sandberg Lundblad; Kim Brøsen
Journal:  Eur J Clin Pharmacol       Date:  2005-07-16       Impact factor: 2.953

6.  Elevated serum pesticide levels and risk of Parkinson disease.

Authors:  Jason R Richardson; Stuart L Shalat; Brian Buckley; Bozena Winnik; Padraig O'Suilleabhain; Ramon Diaz-Arrastia; Joan Reisch; Dwight C German
Journal:  Arch Neurol       Date:  2009-07

7.  Recommendations of the Global Multiple System Atrophy Research Roadmap Meeting.

Authors:  Ryan R Walsh; Florian Krismer; Wendy R Galpern; Gregor K Wenning; Phillip A Low; Glenda Halliday; Walter J Koroshetz; Janice Holton; Niall P Quinn; Olivier Rascol; Leslie M Shaw; David Eidelberg; Pam Bower; Jeffrey L Cummings; Victor Abler; Judy Biedenharn; Gal Bitan; David J Brooks; Patrik Brundin; Hubert Fernandez; Philip Fortier; Roy Freeman; Thomas Gasser; Art Hewitt; Günter U Höglinger; Matt J Huentelman; Poul H Jensen; Andreas Jeromin; Un Jung Kang; Horacio Kaufmann; Lawrence Kellerman; Vikram Khurana; Thomas Klockgether; Woojin Scott Kim; Carol Langer; Peter LeWitt; Eliezer Masliah; Wassilios Meissner; Ronald Melki; Susanne Ostrowitzki; Steven Piantadosi; Werner Poewe; David Robertson; Cyndi Roemer; Dale Schenk; Michael Schlossmacher; Jeremy D Schmahmann; Klaus Seppi; Lily Shih; Andrew Siderowf; Glenn T Stebbins; Nadia Stefanova; Shoji Tsuji; Sharon Sutton; Jing Zhang
Journal:  Neurology       Date:  2017-12-13       Impact factor: 9.910

8.  Spatial distribution of Parkinson's disease mortality in Spain, 1989-1998, as a guide for focused aetiological research or health-care intervention.

Authors:  Jesús de Pedro-Cuesta; Eduard Rodríguez-Farré; Gonzalo Lopez-Abente
Journal:  BMC Public Health       Date:  2009-12-02       Impact factor: 3.295

9.  Use of a medication-based algorithm to identify advanced Parkinson's disease in administrative claims data: Associations with claims-based indicators of disease severity.

Authors:  Nabila Dahodwala; Amy R Pettit; Jordan Jahnke; Pengxiang Li; Vrushabh P Ladage; Prasanna L Kandukuri; Jorge Zamudio; Yash J Jalundhwala; Jalpa A Doshi
Journal:  Clin Park Relat Disord       Date:  2020-02-26

10.  Autism in the Faroe Islands: diagnostic stability from childhood to early adult life.

Authors:  Eva Kočovská; Eva Billstedt; Asa Ellefsen; Hanna Kampmann; I Carina Gillberg; Rannvá Biskupstø; Guðrið Andorsdóttir; Tormóður Stóra; Helen Minnis; Christopher Gillberg
Journal:  ScientificWorldJournal       Date:  2013-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.